发明名称 Arsenic medicaments for the treatment of the chronic asthenia syndrome
摘要 The object of my invention is to provide a very safe and active drug against the new infectious disease called Chronic Asthenia Syndrome. This illness is characterized by chronic debilitation and anorexia, mild fever, myalgia, momentary paresis, generalized muscle weakness, tendency to sleeping, losing weight and resistance to perform the normal activity. Laboratory findings are represented by high levels of Creatine Phosphokinase (CPK) and Creatinine, Magnesium deficiency, decreased haematocrit and Mean Corpuscular Volume (MCV), hypogammaglobulinaemia, eosinophilia and Monocytosis. The intravenous injection of 0.1 milliliter of Caparsolate or Filaramide per Kilogram of body weight made twice, at a distance of 24 hours, can resolve the symptoms and the aetiology of the infectious disease called Chronic Asthenia Syndrome. The Arsenic, and all his organic and inorganic compounds, works as very good drugs against Chronic Asthenia Syndrome.
申请公布号 AU5160193(A) 申请公布日期 1994.10.11
申请号 AU19930051601 申请日期 1993.09.08
申请人 WALTER TARELLO;ANNA SANTAMARIA 发明人 WALTER TARELLO;ANNA SANTAMARIA
分类号 A61K31/285;A61K33/36 主分类号 A61K31/285
代理机构 代理人
主权项
地址